José Laurent Cohen

9PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targetsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 19, 2024
TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.

Anais Debesset, Caroline Pilon, Sylvain Meunier

|May 30, 2023
Author Correction: CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.

Leticia Laura Niborski, Paul Gueguen, Mengliang Ye

|Sep 09, 2022
Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression.

Matteo Ponzo, Anais Debesset, Mélissande Cossutta

|Jun 29, 2022
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas.

Leticia Laura Niborski, Paul Gueguen, Mengliang Ye

|Apr 07, 2022
TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation.

Audrey Moatti, Anais Debesset, Caroline Pilon

Pageof 2